Menu
GeneBe

1-74198286-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_003838.5(FPGT):c.8C>A(p.Ala3Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

FPGT
NM_003838.5 missense

Scores

1
3
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.805
Variant links:
Genes affected
FPGT (HGNC:3825): (fucose-1-phosphate guanylyltransferase) L-fucose is a key sugar in glycoproteins and other complex carbohydrates since it may be involved in many of the functional roles of these macromolecules, such as in cell-cell recognition. The fucosyl donor for these fucosylated oligosaccharides is GDP-beta-L-fucose. There are two alternate pathways for the biosynthesis of GDP-fucose; the major pathway converts GDP-alpha-D-mannose to GDP-beta-L-fucose. The protein encoded by this gene participates in an alternate pathway that is present in certain mammalian tissues, such as liver and kidney, and appears to function as a salvage pathway to reutilize L-fucose arising from the turnover of glycoproteins and glycolipids. This pathway involves the phosphorylation of L-fucose to form beta-L-fucose-1-phosphate, and then condensation of the beta-L-fucose-1-phosphate with GTP by fucose-1-phosphate guanylyltransferase to form GDP-beta-L-fucose. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring downstream TNNI3 interacting kinase (TNNI3K) gene. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.09584132).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FPGTNM_003838.5 linkuse as main transcriptc.8C>A p.Ala3Asp missense_variant 1/4 ENST00000370898.9
FPGT-TNNI3KNM_001112808.3 linkuse as main transcriptc.8C>A p.Ala3Asp missense_variant 1/27

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FPGTENST00000370898.9 linkuse as main transcriptc.8C>A p.Ala3Asp missense_variant 1/41 NM_003838.5 P1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 26, 2022The c.8C>A (p.A3D) alteration is located in exon 1 (coding exon 1) of the FPGT gene. This alteration results from a C to A substitution at nucleotide position 8, causing the alanine (A) at amino acid position 3 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Uncertain
0.020
Cadd
Benign
15
Dann
Uncertain
0.99
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.79
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.64
T;T;T;T;T;T;T;T;T;T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.096
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.95
T
MutationTaster
Benign
1.0
N;N;N;N;N;N;N;N
REVEL
Uncertain
0.29
Sift4G
Benign
0.068
T;D;D;D;D;D;D;D;D;D
Vest4
0.63
MutPred
0.14
.;.;Loss of glycosylation at P7 (P = 0.1765);Loss of glycosylation at P7 (P = 0.1765);Loss of glycosylation at P7 (P = 0.1765);.;Loss of glycosylation at P7 (P = 0.1765);Loss of glycosylation at P7 (P = 0.1765);Loss of glycosylation at P7 (P = 0.1765);Loss of glycosylation at P7 (P = 0.1765);
MVP
0.53
MPC
0.028
ClinPred
0.24
T
GERP RS
1.3
Varity_R
0.19
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-74663970; API